Seven of the nine fusions frequently detected in patients with HCC included: MAN2A1–FER (100%), SLC45A2–AMACR (62.3%), ZMPSTE24–ZMYM4 (62.3%), PTEN–NOLC1 (57.4%), CCNH–C5orf30 (55.7%), STAMBPL1–FAS (26.2%), and PCMTD1–SNTG1 (16.4%). Here, NOLC1 is linked to hepatocellular carcinoma.